Sifting through countless of stocks in the Health Care Equipment & Supplies industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Globus Medical, Inc. or AdaptHealth Corp. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Globus Medical, Inc. and AdaptHealth Corp. compare based on key financial metrics to determine which better meets your investment needs.

About Globus Medical, Inc. and AdaptHealth Corp.

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.

Latest Health Care Equipment & Supplies and Globus Medical, Inc., AdaptHealth Corp. Stock News

As of September 1, 2026, Globus Medical, Inc. had a $10.8 billion market capitalization, compared to the Health Care Equipment & Supplies median of $405.9 million. Globus Medical, Inc.’s stock is down 7.2% in 2026, down 2.5% in the previous five trading days and up 31.35% in the past year.

Currently, Globus Medical, Inc.’s price-earnings ratio is 20.6. Globus Medical, Inc.’s trailing 12-month revenue is $3.1 billion with a 17.0% net profit margin. Year-over-year quarterly sales growth most recently was 5.9%. Analysts expect adjusted earnings to reach $5.000 per share for the current fiscal year. Globus Medical, Inc. does not currently pay a dividend.

As of September 1, 2026, AdaptHealth Corp. had a $735.1 million market cap, putting it in the 41st percentile of all stocks. AdaptHealth Corp.’s stock is down 38.7% in 2026, up 7.7% in the previous five trading days and down 41.94% in the past year.

Currently, AdaptHealth Corp. does not have a price-earnings ratio. AdaptHealth Corp.’s trailing 12-month revenue is $3.4 billion with a -6.8% net profit margin. Year-over-year quarterly sales growth most recently was 12.7%. Analysts expect adjusted earnings to reach $-0.454 per share for the current fiscal year. AdaptHealth Corp. does not currently pay a dividend.

How We Compare Globus Medical, Inc. and AdaptHealth Corp. Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Globus Medical, Inc. and AdaptHealth Corp.’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Globus Medical, Inc. and AdaptHealth Corp. Stock Value Grades

Company	Ticker	Value
Globus Medical, Inc.	GMED	C
AdaptHealth Corp.	AHCO	A

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection.

Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

AAII’s A+ Investor Value Grade derives from a stock’s value score. The Value Score is the percentile rank of the average of the percentile ranks of the price-to-sales ratio, price-earnings ratio, enterprise-value-to-EBITDA (EV/EBITDA) ratio, shareholder yield, price-to-book-value ratio and price-to-free-cash-flow ratio. The score is variable, meaning it can consider all six ratios or, should any of the six ratios not be valid, the remaining ratios that are valid. To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are a good value and so on.

Globus Medical, Inc. has a Value Score of 47, which is Average. AdaptHealth Corp. has a Value Score of 83, which is Deep Value.

The Value Stock Winner: AdaptHealth Corp.

As you can clearly see from the Value Grade breakdown above, AdaptHealth Corp. is considered to have better value than Globus Medical, Inc.. For investors who focus solely on a company’s valuation, AdaptHealth Corp. could be a good stock to add to their portfolio. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Globus Medical, Inc. and AdaptHealth Corp.’s Quality Grades

Company	Ticker	Quality
Globus Medical, Inc.	GMED	A
AdaptHealth Corp.	AHCO	C

Like the Value Grade, AAII’s A+ Investor Quality Grade comes from the percentile rank of key metrics. Specifically, the Quality Score is the percentile rank of the average of the percentile ranks of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and the F-Score.

The score is variable, meaning it can consider all eight measures or, should any of the eight measures not be valid, the remaining measures that are valid. To be assigned a Quality Score, stocks must have a valid (non-null) measure and corresponding ranking for at least four of the eight quality measures.

The Quality Score is used to assess the underlying “quality” of a particular stock. A higher-quality stock possesses traits associated with upside potential and reduced downside risk. Backtesting of the Quality Grade shows that stocks with higher grades, on average, outperformed stocks with lower grades over the period of 1998 through 2019.

Stocks receive better grades (higher scores) for having higher scores for the quality subcomponents and worse grades (lower scores) for lower scores for the subcomponents.

Globus Medical, Inc. has a Quality Score of 98, which is Very Strong. AdaptHealth Corp. has a Quality Score of 46, which is Average.

The Quality Grade Winner: Globus Medical, Inc.

As you can clearly see from the Quality Grade breakdown above, Globus Medical, Inc. has a better overall quality grade than AdaptHealth Corp.. For investors who are looking for companies with higher quality than others in the same industry, Globus Medical, Inc. could be a good stock to add to their portfolios. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Globus Medical, Inc. and AdaptHealth Corp.’s Estimate Revisions Grades

Company	Ticker	Earnings Estimate
Globus Medical, Inc.	GMED	B
AdaptHealth Corp.	AHCO	F

Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.

Globus Medical, Inc. has a Earnings Estimate Score of 80, which is Positive. AdaptHealth Corp. has a Earnings Estimate Score of 4, which is Very Negative.

The Earnings Estimate Revisions Grade Winner: Globus Medical, Inc.

As you can clearly see from the Earnings Estimate Revisions Grade breakdown above, Globus Medical, Inc. has a better Earnings Estimate Revisions Grade than AdaptHealth Corp.. For those who are specifically looking for companies with better short-term prospects when compared to other companies in the same industry, Globus Medical, Inc. could be a good stock to invest in. However, it’s important to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Other Globus Medical, Inc. and AdaptHealth Corp. Grades

In addition to Estimate Revisions, Quality and Value, A+ Investor also provides grades for Growth and Momentum.

Momentum grades help uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming.

Growth investing builds on the idea that stocks of companies exhibiting strong, consistent and prolonged growth outperform those of slower-growth companies. AAII measures growth through consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Globus Medical, Inc. and AdaptHealth Corp. pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Globus Medical, Inc. or AdaptHealth Corp. Stock?

Overall, Globus Medical, Inc. stock has a Value Score of 47, Estimate Revisions Score of 80 and Quality Score of 98.

AdaptHealth Corp. stock has a Value Score of 83, Estimate Revisions Score of 4 and Quality Score of 46.

Comparing Globus Medical, Inc. and AdaptHealth Corp.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.